About Tim Boris
Tim Boris is a director at Vogenx.
Form D filings also name Tim Boris as a director at Elucida Oncology.
Tim Boris reports to the SEC as a director or officer of 5 public companies, including Adhera Therapeutics (ATRX), Greenwood Hall (ERLN) and Spendsmart Networks (SSPC).
Tim Boris first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Tim Boris in the role, so the role may have started earlier or lasted longer.
AI
Adhera Therapeutics, Inc.
Director
2018 · Public company (ATRX)
GI
Greenwood Hall, Inc.
Chief Operating Officer
2017 · Public company (ERLN)
SI
Spendsmart Networks, Inc.
General Counsel
2015 · Public company (SSPC)
CI
CervoMed Inc.
VP Legal Affairs & Secretary, director
2014 · Public company (CRVO)
Key Colleagues at Startups
The people Tim Boris works with at each company, as listed on that company's latest Form D.
Vogenx, Inc. · Form D, Jan 7, 2026
WW
William Wilkison
Executive officer and director
PP
Pete Pieraccini
Director
SD
Steven Delmar
Chief Financial Officer and director
RG
Richard Gorman
Director
JG
James Green
Executive officer and director
Elucida Oncology, Inc. · Form D/A, Aug 3, 2023
RR
Robert Ruffolo
Director
DZ
David Zacardelli
Director
UW
Ulrich Wiesner
Director
GS
Gary Sender
Director
RE
Robert Essner
Executive officer and director
NM
Natalie MacDonald
Director
GG
Geno Germano
CEO and director